Attached files
| file | filename |
|---|---|
| EX-10.5 - EXHIBIT 10.5 - Shuttle Pharmaceuticals, Inc. | s104853_ex10-5.htm |
| EX-10.4 - EXHIBIT 10.4 - Shuttle Pharmaceuticals, Inc. | s104853_ex10-4.htm |
| EX-10.3 - EXHIBIT 10.3 - Shuttle Pharmaceuticals, Inc. | s104853_ex10-3.htm |
| EX-10.2 - EXHIBIT 10.2 - Shuttle Pharmaceuticals, Inc. | s104853_ex10-2.htm |
| EX-3.2 - EXHIBIT 3.2 - Shuttle Pharmaceuticals, Inc. | s104853_ex3-2.htm |
| EX-3.1 - EXHIBIT 3.1 - Shuttle Pharmaceuticals, Inc. | s104853_ex3-1.htm |
| S-1 - S-1 - Shuttle Pharmaceuticals, Inc. | s104853_s1.htm |
Exhibit 23.1
Shuttle Pharmaceuticals, Inc.
1 Research Court, Suite 450
Rockville, Maryland 20850
Gentlemen:
We consent to the use in this Registration Statement on Form S-1 of our report dated November 14, 2016 relating to the financial statements of Shuttle Pharmaceuticals, LLC. as of and for the years ended December 31, 2015 and 2014, and to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Paritz & Company, P.A.
Paritz & Company, P.A.
Hackensack, New Jersey
December 9, 2016